𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence

✍ Scribed by Charles P. O’Brien

Book ID
107551737
Publisher
Springer
Year
2005
Tongue
English
Weight
102 KB
Volume
7
Category
Article
ISSN
1523-3812

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, tolerability, and feasibility of
Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study
✍ Gihyun Yoon; Suck Won Kim; Paul Thuras; Joseph Westermeyer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Objective Prior trials testing standard-dose naltrexone (50 mg/day) have generated mixed results in the treatment of alcohol dependence. The purpose of this study was to evaluate the short-term safety, tolerability, and feasibility of high-dose naltrexone (150 mg/day) for treating alcohol-dependent

Long-term tolerability and efficacy of c
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
✍ R. Inzelberg; P. Nisipeanu; M. J. Rabey; Prof. A. D. Korczyn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 2 views

## Abstract Motor fluctuations constitute a severe complication of chronic levodopa therapy. The addition of dopamine agonists may partially alleviate these responses; however, due to the short half‐lefe of these drugs, several daily doses are required. Cabergoline is a new dopamine agonist with a